NewsRx

Search our medical news database

Drug Law Weekly

Susan Hasty, Publisher

Table of Contents . . . May 31st, 2005

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Drug Law Weekly | Other Publications

Arena Pharmaceuticals, Inc. - European patent issued for 5-HT2C receptor modulators

Ark Therapeutics Group plc - International patents granted for Vitor

BioMarin Pharmaceutical, Inc. - Rights acquired to 6R-BH4 for treating vascular dysfunction

Cephalon, Inc. - Company provides update on patent litigation matters

Children's Hospital of Philadelphia - Is the vaccine industry ailing?

Consumers Union - Law must ensure drug ads accurately inform of risks

Dermisonics, Inc. - Patent office issues notice of allowance for transdermal drug-delivery device

Healthcare Coverage - Highmark enables individuals to take advantage of health savings accounts

InforMedix Holdings, Inc. - Device improves patient medication adherence in schizophrenia trial

Matrixx Initiatives, Inc. - OTC pharma company announces first quarter 2005 financial results

Osteoporosis - Experts: Osteoporosis not a healthcare priority for patients or physicians

Osteoporosis - Group says bone loss is not a healthcare priority for patients or physicians

Perrigo Company - Pharma company reports net loss of $5.15 per share

Phylogica Ltd - Drug discovery company secures patent for gene fragment libraries

Seattle Genetics, Inc. - U.S. patent relating to antibody-drug conjugate technology granted

AMS Health Sciences, Inc. - Nutritional supplements company reports loss of $0.19 per share

Acuity Pharmaceuticals - Ophthalmic pharmaceutical firm forms scientific advisory board

Adolor Corporation - Alvimopan effective for treatment of opioid-induced bowel dysfunction

Aesthera Corp. - Aesthera Photopneumatic System approved by U.S. FDA

Alfred I. duPont Hospital for Children, Wilmington - Soft-tissue release effective for children with spastic hip subluxation

American Psychiatric Association - Survey shows mental illness stigmas are receding, but misconceptions remain

Ascend Therapeutics - Phase II trial results presented for transdermal 4-hydroxytamoxifen therapy

Aston University, West Midlands - Amino acids make aerosolized gene delivery more robust

AstraZeneca - Data show Cerovive reduces disability in patients with acute ischemic stroke

Avecia - Manufacturing agreement signed for ProMune

Avidia, Inc. - Biopharmaceutical firm raises $28.5M in series B financing

Bausch & Lomb - Two-year data from clinical trial of noninfectious uveitis therapy presented

Baxa Corporation - New PhaSeal system component launched for accessing needleless connectors

Bayhill Therapeutics, Inc. - Drug developer raises $35.4M in series B financing

Baylor College of Medicine - TNF-alpha reduces endothelial cell expression of thrombomodulin and EPCR

Beckman Coulter, Inc. - HemosIL D-Dimer assay cleared to aid diagnosis of DVT, pulmonary embolism

BioDelivery Sciences International, Inc. - NDA submitted to U.S. FDA for Emezine

BioDelivery Sciences International, Inc. - William S. Poole appointed to drug delivery company's board of directors

BioSante Pharmaceuticals, Inc. - CaP manufacturing agreement signed

BioVex, Ltd. - IND submitted to U.S. FDA for trial of malignant melanoma therapy

Boston University - Community efforts can reduce alcohol fatalities

Burrill & Company - Biotech gets a much needed boost in April

CV Therapeutics, Inc. - Pharmaceutical firm reports loss of $1.31 per share

Cadence Pharmaceuticals, Inc. - Pharmaceutical company appoints Kenneth Heilbrunn as senior VP

Cangene - FDA approves Vaccinia immune globulin for some reactions to smallpox vaccine

Caron Foundation - Alcoholism is a major healthcare crisis

Celera Genomics - Genomics company files IND application for HDAC inhibitor, CRA-024781

Center for Disease Control and Prevention - Reports describe recent advances in tuberculosis research

Centocor Inc. - New findings in the area of immunology described

Centre Hospitalier Lyon Sud - Preoperative staging offered high prognostic value in rectal cancer

Chiang Mai University - P-glycoprotein function and expression inhibited by kaempferol and quercetin

Children's Hospital & Reg. Med. Cntr., Seattle - New study compares influenza vaccine schedules in children

Chonnam National University, Kwangju - Brain-specific angiogenesis inhibitor 1 restricts corneal neovascularization

City Hospital of Zurich - Potential risk of secondary cancer induction assessed by organ equivalent dose

Colorado State University, Fort Collins - Refeeding after chronic dietary energy restriction reverses anticancer effect

Compex Technologies - EMS products maker announces FDA clearance of IF 3WAVE interferential device

Cook, Inc. - Trial begins for paclitaxel-eluting stent for PAD

Copernicus Therapeutics, Inc. - Company receives orphan drug designation for cystic fibrosis treatment

Copernicus Therapeutics, Inc. - DNA drug delivery being developed for eye diseases

Cumhuriyet University - Fasting does not increase risk of ceftriaxone-associated pseudolithiasis

Cutting Edge Information - Peer review, impact factor among top criteria for medical publication selection

Deltex Medical Group, plc - Study: CardioQ reduces hospital stay by 2 days in colorectal surgery patients

Diet & Nutrition - Health claim supported for garlic in the prevention of heart disease

Dimock Community Health Center, Boston - Methadone clinics promote access to hepatitis C screening and treatment

Duke University - Morphine for chest pain increases death risk

ELA Medical - FDA grants clearance for technology that reduces unnecessary ventricular pacing

Erasmus Medical Center Sophia - Propofol 6% used successfully as sedative in young children

Exelixis, Inc. - Company files IND application for anticancer compound XL844

Guidant Corporation - Approval granted to begin U.S. drug eluting stent trial

Infectious Diseases - A new study examines how shared pathogens affect host populations

Institute of Medicine - Human resource crisis in HIV/AIDS, IOM says

NIR Diagnostics Inc. - Diagnostics company announces financial and operational results

Oscient Pharmaceuticals Corporation - Pharmaceutical company reports first quarter financial results

Sangamo BioSciences, Inc. - Clinical trial initiated for therapy to regenerate nerve function in diabetics

St. Jude Children's Research Hospital - Lab model overcomes limits on human hematopoietic stem cell studies

Tercica, Inc. - FDA accepts Increlex NDA with priority review for the treatment of short stature

U.S. Food & Drug Administration - Residual dipolar couplings used to detect motion in sucrose

Vasomedical, Inc. - Cardio-focused company restructures to pursue congestive heart failure market

Weizmann Inst. of Science, Israel - Scientists reveal system of embryonic law and order

Yale University -  Legionella pneumophila antigens studied, macrophage processing clarified

deCODE genetics - Gene discovery biopharmaceutical company reports Q1 2005 financial results

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook